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ZebraﬁshTaking into account the concept of the “Trojan Horse”, where contaminants may have its entry into speciﬁc
organs potentiated by its association with nanomaterials, the aim of this study was to analyze the joint toxic
effects induced by an organic nanomaterial, fullerene (C60) with the metalloid arsenic (As
III). Hepatocytes of
zebraﬁsh Danio rerio were exposed to AsIII (2.5 or 100 μM), C60 or As+C60 for 4 h, not altering cells viability.
Intracellular reactive oxygen species concentration was reduced in cells exposed only to the C60 (1 mg/L) and
in the treatment of 100 μM AsIII+C60. Co-exposure with C60 abolished the peak of the antioxidant glutathione
(GSH) registered in cells exposed to the lowest AsIII concentration (2.5 μM). A similar result was observed in
terms of lipid damage (TBARS). Total antioxidant capacity was signiﬁcantly higher at both AsIII concentrations
co-exposed to C60when comparedwith the control group. Activity of glutathione-S-transferase omega, a limiting
enzyme in themethylation pathway of AsIII, was reduced in the 100 μMAsIII+C60 treatment. Cells co-exposed to
C60 had a signiﬁcantly higher accumulation of AsIII, showing a “TrojanHorse” effectwhich did not result in higher
cell toxicity. Instead, co-exposure of AsIII with C60 showed to reduce cellular injury.icas (ICB), Universidade Federal
rande, RS, Brazil. Tel.: +55 53
br (J.M. Monserrat).
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Despite the growing demand for products originated from nano-
technology, little is known about the impacts to biological systems
(Kahru and Dubourguier, 2010). Among nanomaterials, fullerenes
(C60 and C70, among others), are carbon molecules possessing only
carbon atoms, forming a chemical structure resembling a soccer
ball. Due to its three-dimensional shape, its unsaturated bonds and
its electronic structure, fullerenes have unique chemical and physical
properties which that can be exploited in several areas of biochemis-
try and medicine (Usenko et al., 2008). Because of its lipophilic na-
ture, it can cross membranes and the blood–brain barrier (Porter
et al., 2007). Taking into account its potential ability to move to differ-
ent cellular compartments, concerns about the toxicity exerted by
this nanomaterial has been raised (Oberdörster, 2004; Oberdörster
et al., 2007; Kahru and Dubourguier, 2010).
It has been registered in ﬁsh species after exposure to fullerene, in-
creased activity of antioxidant enzymes such a catalase (CAT) in liver,
whereas the antioxidant glutathione (GSH) decreased in all tissues test-
ed. Moreover, the total animal weight and length signiﬁcantly decreasedshowing that fullerene had an inhibitory effect on ﬁsh growth (Zhu et al.,
2008). In previous work, it was found a decrease of the antioxidant glu-
tathione (GSH) levels in gills of ﬁshMicropterus salmoides and also lipid
peroxidation (LPO) in the brain after 48 h of exposure to 0.5 mg of
C60/L, indicating that in this case, this nanomaterial presented potential
to generate oxidative stress (Oberdörster, 2004). Other studies described
fullerene as a free radical producer, with a strong oxidative potential by
photo activation, inducing toxicity in cell culture (Kamat, 2002; Mori
et al., 2006; Usenko et al., 2007; Shinohara et al., 2009).
On the other hand, some studies have reported fullerene as being
a powerful antioxidant. Other study showed that the levels of LPO de-
creased after exposure to fullerene, especially in the gills and brain
(Zhu et al., 2008). Exposure of fullerene in rats also showed in vivo an-
tioxidant effects, without presenting acute or sub-acute toxicity
(Gharbi et al., 2005). This divergence of information led to assessment
studies on the deleterious effects of carbon nanomaterials, such as
fullerene, to be increased in recent years (Oberdörster et al., 2005;
Aschberger et al., 2010), raising the need of establish under which
conditions these nanoparticles can behave as anti- or pro-oxidants.
Limbach et al. (2007) observed that the production of reactive ox-
ygen species (ROS) in lung epithelial cells exposed to cobalt andman-
ganese co-exposed to silica nanoparticles was 8 times higher
compared to the controls. The authors proposed that silica nanoparti-
cles acted as carries of metals, playing a ‘Trojan horse’ role. Also, Sun
et al. (2009) reported that the co-exposure to nanoparticles of
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tion of arsenite in gills, viscera and muscle of carp after 25 days of ex-
posure. The study of Baun et al. (2008) evaluated toxic responses in
the algae Pseudokirchneriella subcapitata and the microcrustacean
Daphnia magna after co-exposure of fullerene with several organic
xenobiotic. They found in P. subcapitata that fullerene increased 60%
phenanthrene toxicity, whereas a decreased toxicity was registered
for pentachlorophenol when co-exposed with the nanomaterial. For D.
magna fullerene modiﬁed phenantherene and pentachlorophenol tox-
icity in the same way as for P. subcapitata.
Arsenic is a toxic molecule and it is of interest to evaluate its poten-
tial interactionwith fullerene. Is a metalloid found in water, soil, and air
from natural and anthropogenic sources, existing both in inorganic and
organic forms, with different oxidation states (Ventura-Lima et al.,
2011). The metabolism of arsenic has an important role in its toxic ef-
fects. Inorganic arsenic is metabolized by a sequential process involving
a two-electron reduction of pentavalent arsenic to trivalent arsenic, fol-
lowed by oxidative methylation to pentavalent organic form (Thomas
et al., 2001). The reduction can occur non-enzymatically in the presence
of a thiol such as glutathione (GSH) (Delnomdedieu et al., 1994; Xuexia
et al., 2008). All forms of inorganic arsenic, even at low concentration
and short exposure time can trigger ROS generation (Schuliga et al.,
2002; Chowdhury et al., 2010; Ventura-Lima et al., 2011).
Enzymes of the glutathione-S-transferase (GST) type are a multi-
functional group of proteins involved in the detoxiﬁcation of xenobi-
otics, being found in almost all living organisms. In this group it is
included the omega glutathione-S-transferase omega (GST Ω), acting
in the process of arsenic methylation (Sakurai et al., 2005; Ventura-
Lima et al., 2011). In this way, reductions of monomethylarsenate acid
(MMAV) to monomethylarsenite acid (MMAIII), and dimethylarsenate
acid (DMAV) to dimethylarsenite acid (DMAIII) are catalyzed by GSTΩ.
This enzyme is crucial for the pathway of methylation of inorganic As,
since only arsenic species that have an oxidation state of +3 can be
methylated (Chowdhury et al., 2006).
Taking into account the ‘Trojan horse’ effect (Limbach et al., 2007),
fullerene may increase As toxicity. Furthermore, with the rapid
growth of nanotechnology, it becomes essential to understand the
potential biological consequences of the association of fullerene
with important contaminants, such as arsenic, especially at a time
when the use of products derived from these new technologies is in-
creasing every day (Fischer and Chan, 2007). In present study we
employed the ZFL line, a zebraﬁsh hepatocyte model that was previ-
ously employed to study the toxicity of copper and several pharma-
ceuticals (Pomati et al., 2007; Chen and Chan, 2011). Chen and Chan
(2011) showed that, after copper exposure, 50% of differentially
expressed proteins in ZFL line were the same to that observed in tila-
pia hepatocytes, including ROS-related proteins. The ZFL line has been
also employed as model to evaluate toxicological responses to phar-
maceuticals, being employed an in silico approach to compare the ob-
served transcriptional changes in this cell line with those observed in
zebraﬁsh liver tumors (Pomati et al., 2007).
2. Materials and methods
2.1. Fullerene
Previous evidence showed that preparation of fullerene suspensions
with organic solvents like tetrahydrofuran (THF) induced toxic re-
sponses that were mainly related to degradation products of these sol-
vents (Zhu et al., 2006; Henry et al., 2007). So, an aqueous fullerene
suspensionwas prepared, where 200 mg of fullerene (SES research, pu-
rity: 99%)were diluted in 1 LMilliQwater and kept under constant stir-
ring and ﬂuorescent light during 2 months. In this way, any toxic effects
that may be registered will not be due to presence of solvents that can
be trapped in fullerene aggregates not generating toxicity that could
be assigned to the fullerene (Oberdörster et al., 2006; Henry et al.,2007). After stirring, suspensions were centrifuged at 25,000 g for 1 h
at 15 °C to promote sedimentation of large aggregates and sequentially
ﬁltered through 0.45 and 0.20 μm pore membranes. Fullerene concen-
tration was estimated by measuring total carbon concentration with a
TOC-V CPH (Shimadzu) total organic carbon analyzer. The ﬁnal concen-
tration of fullerene used in cell bioassays was 1 mg/L. Filtered C60 sus-
pensions were characterized using a JEOL JSM 1200 EX II transmission
electron microscopy operating at 100 kV. Samples of about 30 μL of
C60 suspension were disposed onto 300 mesh TEM grids (SPI) coated
with Formvar. Analysis was performed after 24 h in order to allow sam-
ple evaporation (Lyon et al., 2006).
2.2. Preparation of arsenic solutions
After previous tests performed by our research group using the
zebraﬁsh liver cell line, the nominal concentrations of AsIII solution
selected to the assay were 2.5 μM and 100 μM. Arsenite solution was
prepared using NaAsO2 (VETEC) dissolved in ultrapure water, always
prepared on the same day of the beginning of the assay. A previous
study reported the use of ﬁnal concentrations ranging from 0 to
300 μM of arsenite during 24 h for the same cell line (Seok et al.,
2007).
2.3. Cell culture
Zebraﬁsh hepatocyte cultures (strain ZFL), obtained from American
Type culture collection(ATCC) were kept at 28 oCin RPMI- 1640 culture
medium supplemented with 10% fetal bovine serum and 1% antibiotic/
antimycotic. Cells (106∕mL)were incubated in 24well cell culture plates
and left to adhere for 24 h, and then, cellswere exposed to 2 arsenic con-
centrations (2.5 and 100 μM) and fullerene (1 mg/L) for 4 h. Four repli-
cates were employed for each treatment: Control (medium culture and
ultrapurewater); 2.5 μMof AsIII; 100 μMof AsIII; Control+C60 (only ful-
lerene added); 2.5 μM of AsIII+C60; 100 μM of AsIII+C60. At least two
assays were performed for each measurement (see below). After expo-
sure in the dark, the cells were washed in PBS, re-suspended with tryp-
sin (0.25% v/v) and stored for later biochemical and analytical analysis.
2.4. Estimation of the cells number
Cell counts were performed with 800 μL of cell suspension (four
cells pool). The cells number of each pool was count under a light mi-
croscope at 40 ×. Serial dilutions were made (100%, 75%, 50% and
25%) for each cell pool, with culture medium. After this, the absor-
bance of each cell suspension was determined in an ELISA plate read-
er (Biotek ELx 800) at 630 nm. With these dilutions, a standard curve
was constructed, ﬁtting the absorbance to the cells number measured
by microscopy. Then, the cell number of each treatment was estimat-
ed by measuring its absorbance at 630 nm.
2.5. Determination of mitochondrial dehydrogenases functionality
Functionality of mitochondrial dehydrogenases was determined by
MTT assay (2-(4, 5-dimethyl-2-thiazolyl)-3, 5-diphenyl-2H-tetrazolium
bromide), after 30 min at 28 °C in the dark, the plate was centrifuged at
600 g for 7 min, the supernatant discarded, DMSO added and read with
an ELISA plate reader (Biotek Lx 800) at 490 nm.
2.6. Determination of the intracellular reactive oxygen species concen-
tration (ROS)
Immediately after exposure, cells were centrifuged at 600 g for
5 min at 10 °C. The cell pellet was re-suspended in PBS containing
2,7′diclorodihidroﬂuorescein diacetate (H2DCF- DA; 40 μM). Fluores-
cence was read at 28 °C during 70 min, using a plate reader ﬂuorime-
ter (Victor 2, Perkin Elmer), with excitation and emission wavelength
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of ﬂuorescence area, after ﬁtting ﬂuorescence data to a second order
polynomial and integrating between 0 and 70 min in order to obtain
the graphic area. The area of ROS was standardized by the number of
viable cells (Ferreira-Cravo et al., 2007).2.7. Measurement of intracellular reduced glutathione (GSH) concentration
This technique is based on the reactivity of 2,3-naphthalene
dicarboxialdehyde (NDA) to react with GSH to form a cyclic and
ﬂuorescent compound. Cells pellets were re-suspended in PBS and
then proteins precipitated with sulfosalicylic acid (ﬁnal concentration:
100 mM). Aliquots of the supernatants were transferred to speciﬁc
microplates for ﬂuorescence detection. NDA was then added to all
wells, and after 30 min of incubation, the ﬂuorescence intensity of the
NDA-GSH complex was read at excitation and emission wavelength of
485 and 530 nm, respectively, using a plate reader ﬂuorimeter (Victor
2, Perkin Elmer) (White et al., 2003).2.8. Determination of lipid oxidative damage
The lipid peroxidation was determined by TBARS (Oakes and Van
Der Kraak, 2003). Thismethod involves the reaction ofmalondialdehyde
(MDA), a degradation product of lipid peroxidation, with thiobarbituric
acid (TBA) under conditions of high temperature and acidity, producing
a chromogenwhichwas quantiﬁed by ﬂuorometry (excitation: 520 nm,
emission: 580 nm). Brieﬂy, after homogenization with PBS, aliquots
of hepatocytes were incubated at 95 °C during 30 min with 35 μM
of butylated hydroxytoluene (BHT), 8.1% sodium dodecyl sulfate
(SDS), 20% acetic acid and 0.8% TBA. After cooling to room
temperature, n-butanol was added, centrifuged at 3000 g for
10 min at 15 °C. Tetramethoxypropane (ACROS Organics) was used
as standard. Fluorescence was read at room temperature using a
plate reader ﬂuorimeter (Victor 2, Perkin Elmer).2.9. Measurement of total antioxidant capacity
Brieﬂy, total antioxidant competence against peroxyl radicals was
analyzed through reactive oxygen species (ROS) determination in
cells extracts treated or not with a peroxyl radical generator. Peroxyl
radicals were produced by thermal (35 °C) decomposition of 2,2′-
azobis 2 methylpropionamidine dihydrochloride (ABAP; 4 mM; Al-
drich) (Winston et al., 1998). Readings were carried out in a ﬂuores-
cence microplate reader (Victor 2, Perkin Elmer), in a medium
containing 30 mM HEPES (pH 7.2), 200 mM KCl, 1 mM MgCl2, 40 μM
H2DCF-DA. Total ﬂuorescence generation (excitation: 485 nm, emis-
sion: 530 nm) was calculated by integrating the ﬂuorescence units
(FU) along the measurement time, after adjusting FU data to a second
order polynomial function. The relative difference between ROS area
with and without ABAP was considered a measure of antioxidant
competence, with high area difference meaning low antioxidant ca-
pacity, since high ﬂuorescence levels were obtaining after adding
ABAP, meaning low competence to neutralize peroxyl radicals
(Amado et al., 2009).2.10. Measurement of glutathione-S-transferase omega (GST Ω) activity
Determination of GST Ω activity was performed by the enzymatic
reduction of MMV, measured spectrophotometrically at 340 nm,
resulting from the oxidation of NADPH. The reduction of MMAV was
measured employing 100 μL of cells extracts (made in PBS), 5 mM
GSH, 30 μM MMV, 0.25 mM NADPH, and 0.8 units of glutathione re-
ductase (Sampayo-Reyes and Zakharyan, 2006).2.11. Measurement of oxidized proteins
Measurement of modiﬁed proteins by oxidation (carbonyl groups)
was performed using an immunoassay commercial kit (OxyELISA,
Millipore) according to manufacturer's instructions. Cells were initial-
ly lysed by icing/thawing with a proper buffer supplemented with
protease inhibitor phenylmethylsulphonylﬂuoride (PMSF) and nor-
malized to 10 μg/mL. Aliquots of the lysates were added to a 96-
wells micro titer plate and incubated for 1 h at 37 Ó°C to adsorb the
proteins on the bottom. The plate was then washed with a proper so-
lution and a dinitrophenylhydrazine (DNPH) solution was added to
cause derivatization of carbonyl groups of the oxidized proteins side
chains, forming 2,4- dinitrophenylhydrazone (DNP-hydrazone) dur-
ing 45 min at 25 °C in the dark. The reaction was stopped with a
blocking solution. The DNP-derivatized proteins were then incubated
with a mouse monoclonal antibody (conjugated to horseradish per-
oxidase, HRP) speciﬁc to the DNP moiety during 1 hour at room tem-
perature. After several washes, samples were incubated with the HRP
substrate 3,3′,5,5′-tetramethylbenzidine (TMB) and absorbance at
620 nm was monitored in a plate reader spectrophotometer (Biotek
Lx 800). Once an optical density of 0.6 to 0.7 was reached (approxi-
mately 30 min), the reaction was stopped by adding a stop solution
and samples were read at 450 nm. Liquid absorbances of the samples
were assumed as a measure of immuno-detection of carbonyl groups
present in proteins.
2.12. Measurement of intracellular arsenic accumulation
Before the determination of total As content, cell pellets were
digested by using an acidic oxidant mixture containing HNO3 and
H2O2. Firstly, a sample amount was weighted, added of 10 mL of con-
centrated HNO3 and heated at 95 °C for 15 min (without boiling).
After cooling, it was added of 5 mL concentrated HNO3 and reﬂuxed
once again for 30 min (95 °C). This sample volume was then reduced
up to 5 mL and, after cooling, 2 mL of H2O and 3 mL of H2O2 30% were
added to the digestion tubes. The solution was heated and 30% H2O2
(1 mL aliquots) was added until diminishing the solution efferves-
cence. The solution was ﬁnally cooled down and diluted to 50 mL
with ultrapure water. The determination of As in the digested sam-
ples were made by using a calibration curve ranging from 1.0 to
10.0 μg/L of total As. Measurements were performed in a SpectrAA
200 atomic absorption spectrometer (Varian, Australia), equipped
with a VGA 77 system for continuous ﬂow hydride generation. The
operating conditions of the spectrometer for the determination of ar-
senic were the following: wavelength 193.7 nm; bandwidth 0.5 nm;
lamp current 12 mA. Hydride generation was conducted carrying
the reductant, 1% (m/v) sodium tetrahydroborate (III) in 250 mM
NaOH, and 6.0 M HCl, at a ﬂow rate of 1.0 mL/min, and sample at a
ﬂow rate of 8.0 mL/min. The atomization temperature was 925 °C.
2.13. Statistical analysis
All results were expressed asmean±standard deviation. Signiﬁcant
differences were assessed by two-factorial analysis of variance
(ANOVA), being the factors AsIII concentration (0; 2.5 or 100 μM) and
C60 concentration (0 or 1 mg/L). Post hoc comparisons were performed
using the Newman-Keuls test or orthogonal contrasts. In all cases, type I
error probability was ﬁxed in 5%. ANOVA assumptions (normality and
variance homogeneity) were previously checked (Zar, 1984).
3. Results
As shown in Fig. 1, C60 suspensions employed in the assays
showed a prevalence of nano-aggregates, as previously reported by
Lyon et al. (2006) using the same procedure of stirring C60 in Milli
Q water without adding organic solvents. Results of mitochondrial
Fig. 1. Transmission electronic microscopy (TEM) image of the aqueous fullerene (C60)
suspensions employed in the bioassays.
Fig. 3. Arsenic accumulation (μg per cell) by zebraﬁsh hepatocytes after exposure dur-
ing 4 h to 0 (control); 2.5; or 100 μM AsIII with or without fullerene C60 (1 mg/L). Iden-
tical letters means absence of statistical differences (pN0.05). Number of analyzed
samples were 4 for each treatment, being conducted two independent experiments
(n=8).
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be observed that the treatments did not alter the ability of MTT re-
duction (pN0.05) during the 4 h of exposure to 2.5 or 100 μM AsIII,
both in absence or in presence of C60. According to the results pre-
sented in Fig. 2, it was concluded that exposure to AsIII (2.5 and
100 μM) without or with fullerene (1 mg/L) co-exposure during 4 h
caused no signiﬁcant difference in the ability to reduce MTT forming
formazan, demonstrating that these concentrations were sub-lethal
for zebraﬁsh hepatocytes. Cells co-exposed to arsenic and fullerene
registered a signiﬁcant increase in arsenic concentrations in respect
of those treated only with arsenic (pb0.05; Fig. 3).
Intracellular ROS concentration in the 100 μM AsIII+C60 treat-
ment was signiﬁcantly lower when compared with the other treat-
ments (pb0.05; Fig. 4). Also, the Control+C60 group presented a
lower ROS concentration than the control group without C60
(pb0.05; Fig.4).
Intracellular GSH concentration (Fig. 5a) presented a signiﬁcant
increase (pb0.05) at the lowest AsIII concentration (2.5 μM), whichFig. 2. Number of viable zebraﬁsh hepatocytes after exposure during 4 h to 0 (control);
2.5; or 100 μM AsIII with or without fullerene C60 (1 mg/L). Identical letters means ab-
sence of statistical differences (pN0.05). Number of analyzed samples were 4 for each
treatment, being conducted three independent experiments (n=12).was abolished in the presence of C60. Antioxidant capacity data
(Fig. 5b) presented a signiﬁcant interaction (pb0.05) between the
two analyzed factors (arsenic and fullerene exposure). Orthogonal
contrasts showed a relative increase (pb0.05) in total antioxidant
competence against peroxyl radicals in cells exposed to arsenic
(both concentrations) and C60 when compared with the control
group (Fig. 5b).
GST Ω activity (Fig. 6) showed a signiﬁcant reduction (pb0.05) in
cells exposed to 100 μM of AsIII and co-exposed to C60 when com-
pared with cells only exposed to 100 μM of AsIII. The other treatments
did not show statistical differences (pN0.05). TBARS concentration
(Fig. 7a) increased (pb0.05) at the lowest AsIII concentration
(2.5 μM) when compared with the same AsIII concentration in pres-
ence of C60. Levels of oxidized protein (Fig. 7b) showed no signiﬁcant
differences (pN0.05) between treatments.
4. Discussion
When analyzed the oxidative potential of fullerene suspensions, it
has been reported that aqueous fullerene suspensions can act as a po-
tent scavenger of ROS, equivalent to the powerful antioxidant BHT
and even greater than vitamin E (Torres et al., 2011). The results
from this study are consistent with those found here, where a clear
reduction of intracellular ROS concentration was registered inFig. 4. Intracellular reactive oxygen species (ROS) concentration in zebraﬁsh hepato-
cytes after exposure during 4 h to 0 (control); 2.5; or 100 μM AsIII with or without ful-
lerene C60 (1 mg/L). Identical letters means absence of statistical differences (pN0.05).
Number of analyzed samples were 4 for each treatment, being conducted three inde-
pendent experiments (n=12).
Fig. 5. (a) Intracellular concentration of reduced glutathione (GSH) (nM/mg of pro-
teins) in hepatocytes of zebraﬁsh, after exposure during 4 h to 0 (control); 2.5; or
100 μM AsIII with or without fullerene C60 (1 mg/L). Identical letters means absence
of statistical differences (pN0.05). (b) Same as (a) for total antioxidant capacity against
peroxyl radicals (relative area). Asterisk (*) indicates signiﬁcant differences (pb0.05)
between treatments connected by solid lines. In both (a) and (b) the number of ana-
lyzed samples were 4 for each treatment, being conducted three independent experi-
ments (n=12).
Fig. 7. (a) Intracellular concentration of thiobarbituric acid reactive substances (TBARS;
nmol/mg of proteins) in hepatocytes of zebra ﬁsh after exposure during 4 h to 0 (con-
trol); 2.5; or 100 μM AsIII with or without fullerene C60 (1 mg/L). Asterisk (*) indicates
signiﬁcant differences (pb0.05) between treatments connected by solid lines.
(b) Same as (a) for oxidized proteins. Identical letters means absence of statistical dif-
ferences (pN0.05). In (a) and (b), In both (a) and (b) the number of analyzed samples
were 4 for each treatment, being conducted three independent experiments (n=12).
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out fullerene exposure (Fig. 4). The antioxidant properties of fuller-
ene have been reported previously. For example, using human
neuroblastoma cells exposed to 0.1; 10 or 100 μM of C60 during
24 h, it was also observed antioxidant responses, being the fullerene
able to scavenge free radicals produced in these cells (Ehrich et al.,Fig. 6. Activity of glutathione-S-transferase (GST) omega (nmol NADPH/min/mg of
proteins) in hepatocytes of zebra ﬁsh after exposure during 4 h to 0 (control); 2.5; or
100 μM AsIII with or without fullerene C60 (1 mg/L). Asterisk (*) indicates signiﬁcant
differences (pb0.05) between treatments connected by solid lines. Numbers of ana-
lyzed samples were 4 for each treatment, being conducted three independent experi-
ments (n=12).2010). The term of “radical sponge”was coined for fullerene, in virtue
of its scavenging capacity in keratinocytes of human skin irradiated
with visible light (400–2,000 nm) (Xiao et al., 2006). Our results of
total antioxidant capacity also agree with the idea of fullerene being
a “radical sponge”, as showed by cells co-exposed with AsIII (2.5 and
100 μM) and fullerene (1 mg/L) which presented higher antioxidant
capacity (Fig. 5b). In fact, co-exposure of C60 lowered levels of lipid
peroxidation induced at the lowest AsIII concentration (Fig. 7a).
When organisms are exposed to conditions that can cause oxida-
tive stress, antioxidant defenses are activated, GSH being one of the
main antioxidants involved in the preservation of cellular redox status
and defenses against ROS and xenobiotics (White et al., 2003). It was
reported an increase in GSH levels in zebraﬁsh gills after exposure to
10 or 100 μg/L of AsV (Ventura-Lima et al., 2009). Other studies have
demonstrated the effect of inorganic arsenic (as sodium arsenite) in
human keratinocytes cell line, exposed for 24 h at concentrations as
high as 10 μM. It was reported an increased production of hydrogen
peroxide, concomitant with higher levels of GSH (Pi et al., 2003). In
our study, the exposure of zebraﬁsh hepatocytes during 4 h to
2.5 μM of AsIII was already enough to cause an increase in GSH
levels (Fig. 5a). This result indicates a possible oxidant condition eli-
cited by AsIII in the cell, since GSH is considered an importantmediator
of the intracellular redox condition. In the AsIII (2.5 μM)+C60 treat-
ment, the GSH peakwas not observed. Asmentioned above, augment-
ed GSH levels induced by low As concentrations has been previously
reported (Pi et al., 2003; Xiao et al., 2006), suggesting that the fuller-
ene may be sequestering the metalloid and thus abolishing the GSH
response elicited by AsIII alone at the lowest concentration.
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ecules adsorbed to nanoparticles into the cells (Limbach et al., 2007).
Althoughmany studies on the Trojan horse theory are made in a ther-
apeutic sense through the incorporation of substances carried by
nanoparticles (Choi et al., 2007), there are several other studies
showing that Trojan horse theory can act in an environmental context
(Sun et al., 2009). As showed in Fig. 3, C60 in fact favored arsenic ac-
cumulation in zebraﬁsh hepatocytes. However, a higher arsenic accu-
mulation when co-exposed with C60 did not result in higher toxicity.
We mentioned that C60 abolished the GSH and TBARS peaks in cells
exposed to 2.5 μM of AsIII (Fig. 7a). Thus it is important to consider
not only the facilitated entry arsenic in presence of C60 but also the re-
lease of this metalloid from the nanomaterial once inside the cell. For
example, it has been analyzed AsIII and AsV removal efﬁciency by
carbon-based absorbents, being found that different carbon com-
pounds greatly differs in its adsorption capacity, according to the me-
dium pH (Pattanayak et al., 2000). From our results it is evident that
the existence of “Trojan horse” effect does not imply in toxicity syner-
gy, suggesting that the kinetics of toxic molecules release from nano-
particles deserves several studies.
When antioxidant defenses are below the level of oxidants, lipid
peroxidation can be induced, an event widely accepted as a general
mechanism of cellular injury and one of the toxic effects elicited by
arsenic (Ramanathan et al., 2003; Dhar et al., 2005; Flora et al.,
2005; García-Chávez et al., 2006). The increase in lipid peroxidation
at 2.5 μM of AsIII was in parallel with an increment of GSH levels, an
adaptive response that was insufﬁcient to prevent lipid peroxidation.
Interestingly, these two effects were not observed in the AsIII
(2.5 μM)+C60 treatment, indicating that the fullerene may be acting
as an antioxidant protecting the cell against lipid damage and/or low-
ering the intracellular levels of free arsenic, as previously mentioned.
It has been reported that arsenic can cause oxidative damage to pro-
teins due to its high afﬁnity to sulfhydryl groups of proteins (Tseng,
2004). The oxidative damage to proteins is reﬂected by an increase in
the levels of protein carbonyls (PCO), and a decrease in the concentration
of protein thiols (PSH). Also, it is known that a by-product of lipid peroxi-
dation asmalondialdehyde (MDA) can generate PCO (Samuel et al., 2005).
Our results showed a peak of TBARS (an estimator of malondialdehyde
levels)without observed signiﬁcant differences in PCO levels. It is expected
that these two parameters of oxidative damage follows a different time
course, where a peak in MDA should be the earlier responses and a peak
in PCO a later one, not registeredwith the time frame employed in present
study (4 h).
Enzymes of glutathione-S-transferase (GST) group play a key role in
cellular detoxiﬁcation, protecting cells against pollutants or toxicants by
conjugating them to glutathione and other endogenous molecules. The
GST superfamily has been divided into distinct classes knows as alpha,
mu, pi, theta, zeta, sigma and omega (Ω) (Ventura-Lima et al., 2011).
The GST Ω 1 form is involved in the reductive step of arsenate (AsV),
monomethylarsonic acid (MMAV), and dimethylarsonic acid (DMAV).
The second form, GSTΩ 2, was recently identiﬁed and can also catalyze
the reduction ofmonomethylarsonic acid (MMAV) and dimethylarsonic
acid (DMAV) (Agusa et al., 2010). In this way, GST of omega class are
crucial enzymes in the pathway for the reduction of arsenate to arsenite
in the methylation pathway (Chowdhury et al., 2006). We observed a
reduced GST Ω activity in the treatment of AsIII (100 μM)+C60, when
compared with the treatment of 100 μM of AsIII, showing that arsenic
alone provides higher capacity for arsenic methylation. The lowering
of GST Ω activity when AsIII is co-administered with C60 raises again
the idea of arsenic being trapped to fullerene, thus abolishing this enzy-
matic response. Also it raises the question about C60 inﬂuence in As
methylation pathway, a point that urge to be analyzed.
As ﬁnal conclusions it can be stated that the different biochemical
variables analyzed indicate that C60 showed an antioxidant action, re-
ducing the intracellular concentration of reactive oxygen species.
Lipid peroxidation data also showed a signiﬁcant reduction at thelower concentration of As co-exposed to C60. Considering the interac-
tion of this nanomaterial with arsenic, it was clearly stated that the
intracellular concentration of As in cells co-exposed with fullerene
showed signiﬁcantly higher values. Fullerene also showed to modu-
late arsenic metabolization, since it reduced the activity of the en-
zyme GST Ω at the highest concentration of arsenic, and abolished
the peak of GSH concentration registered in cells exposed only to As
at the lowest concentration. It still remains the question about if As
can be released from C60 after some time, which in turn could result
in posterior cell damage. Future studies are needed to evaluate the
bioavailability of intracellular As after co-exposure with C60 in longer
periods than 4 h.
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